Lemonaid Health, a San Francisco, CA-based on-demand platform for accessing healthcare online, raised $33m in Series B funding.
The round, which brought total financing to $55m, was led by Olive Tree Ventures with participation from Artis Ventures, Correlation Ventures, Hikma Ventures, Sierra Ventures and others.
The company intends to use the funds to expand its team of medical professionals and increase the number of services being offered to patients, including treatment for asthma, hypertension, Type 2 diabetes and more mental health services.
Led by Paul Johnson, co-founder and CEO, Lemonaid Health is an independent healthcare provider that offers patients direct access to the care they need, from consultation through treatment nationally across the U.S. The company leverages evidence-based guidelines and the most up-to-date clinical protocols to provide quality care for less than typical co-pays. In a few minutes, patients are able to interact with a U.S.-licensed doctor or nurse practitioner for conditions like anxiety and depression, urinary tract infections (UTIs), birth control, hair loss, hypothyroidism, erectile dysfunction, genital herpes and sinus infections. Patients are also offered free and fast delivery of prescription medications through the platform to speed treatment. Lemonaid Health’s proprietary technology platform integrates clinical algorithms and decision support tools with clinician care to provide quality care and improved outcomes.